AMBEY — Ambey Laboratories Balance Sheet
0.000.00%
- IN₹945.48m
- IN₹1.08bn
- IN₹1.05bn
Annual balance sheet for Ambey Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IAS | IAS | IAS |
Status: | Final | Final | Final |
Cash | |||
Cash and Equivalents | |||
Short Term Investments | |||
Cash and Short Term Investments | 5.12 | 2.89 | 10.2 |
Net Total Accounts Receivable | |||
Net Total Receivables | 73.8 | 90.8 | 37.9 |
Total Inventory | |||
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 200 | 243 | 275 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 155 | 241 | 242 |
Net Intangible Assets | |||
Long Term Investments | |||
Long Term Notes Receivable | |||
Other Long Term Assets | |||
Total Assets | 446 | 559 | 576 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 219 | 216 | 203 |
Long Term Debt | |||
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Deferred Income Tax | |||
Total Other Liabilities | |||
Total Funded Status | |||
Total Liabilities | 525 | 369 | 340 |
Common Stock | |||
Retained Earnings (Accumulated Deficit) | |||
Unrealized Gain / Loss | |||
Total Equity | -78.6 | 191 | 236 |
Total Liabilities & Shareholders' Equity | 446 | 559 | 576 |
Total Common Shares Outstanding |